V.T. Skamnaki

1.7k total citations
45 papers, 1.4k citations indexed

About

V.T. Skamnaki is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, V.T. Skamnaki has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 26 papers in Organic Chemistry and 10 papers in Rheumatology. Recurrent topics in V.T. Skamnaki's work include Carbohydrate Chemistry and Synthesis (24 papers), Biochemical and Molecular Research (16 papers) and Glycosylation and Glycoproteins Research (10 papers). V.T. Skamnaki is often cited by papers focused on Carbohydrate Chemistry and Synthesis (24 papers), Biochemical and Molecular Research (16 papers) and Glycosylation and Glycoproteins Research (10 papers). V.T. Skamnaki collaborates with scholars based in Greece, United Kingdom and Hungary. V.T. Skamnaki's co-authors include L.N. Johnson, Nikos G. Oikonomakos, S.E. Zographos, Katerina E. Tsitsanou, D.D. Leonidas, Nick R. Brown, E.D. Lowe, A.L. Kantsadi, Joseph M. Hayes and Atlanta G. Cook and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

V.T. Skamnaki

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V.T. Skamnaki Greece	22	960	581	204	193	186	45	1.4k
Evangelia D. Chrysina Greece	24	1.2k 1.2×	935 1.6×	225 1.1×	86 0.4×	49 0.3×	64	1.8k
Athanasios Papakyriakou Greece	27	1.0k 1.1×	410 0.7×	123 0.6×	681 3.5×	65 0.3×	95	2.1k
Virginia L. Rath United States	16	871 0.9×	239 0.4×	161 0.8×	50 0.3×	126 0.7×	23	1.2k
Paul D. van Poelje United States	23	1.1k 1.1×	414 0.7×	93 0.5×	231 1.2×	66 0.4×	33	2.1k
Magda Kosmopoulou Greece	19	522 0.5×	400 0.7×	104 0.5×	97 0.5×	103 0.6×	26	925
F. George Njoroge United States	26	853 0.9×	836 1.4×	44 0.2×	180 0.9×	82 0.4×	101	2.5k
Nikos G. Oikonomakos Greece	30	2.0k 2.1×	1.8k 3.1×	566 2.8×	99 0.5×	72 0.4×	81	2.8k
Christopher W. Carreras United States	17	1.1k 1.2×	142 0.2×	107 0.5×	309 1.6×	38 0.2×	35	1.5k
Jon Read United Kingdom	25	1.3k 1.4×	369 0.6×	21 0.1×	199 1.0×	115 0.6×	40	2.1k
Doreen Dobritzsch Sweden	24	1.2k 1.3×	160 0.3×	158 0.8×	403 2.1×	52 0.3×	71	2.0k

Countries citing papers authored by V.T. Skamnaki

Since Specialization

Citations

This map shows the geographic impact of V.T. Skamnaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.T. Skamnaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.T. Skamnaki more than expected).

Fields of papers citing papers by V.T. Skamnaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.T. Skamnaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.T. Skamnaki. The network helps show where V.T. Skamnaki may publish in the future.

Co-authorship network of co-authors of V.T. Skamnaki

This figure shows the co-authorship network connecting the top 25 collaborators of V.T. Skamnaki. A scholar is included among the top collaborators of V.T. Skamnaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.T. Skamnaki. V.T. Skamnaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garagounis, Constantine, et al.. (2021). Mutagenesis of a Lotus japonicus GSK3β/Shaggy-like kinase reveals functionally conserved regulatory residues. Phytochemistry. 186. 112707–112707. 3 indexed citations

Leonidas, D.D., et al.. (2021). Glycogen phosphorylase revisited: extending the resolution of the R- and T-state structures of the free enzyme and in complex with allosteric activators. Acta Crystallographica Section F Structural Biology Communications. 77(9). 303–311. 9 indexed citations

Skamnaki, V.T., S.E. Zographos, Éva Bokor, et al.. (2019). The architecture of hydrogen and sulfur σ-hole interactions explain differences in the inhibitory potency of C-β-d-glucopyranosyl thiazoles, imidazoles and an N-β-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design. Bioorganic & Medicinal Chemistry. 28(1). 115196–115196. 4 indexed citations

Skamnaki, V.T., Colin Moffatt, Nicolas Bischler, et al.. (2015). An evaluation of indirubin analogues as phosphorylase kinase inhibitors. Journal of Molecular Graphics and Modelling. 61. 231–242. 10 indexed citations

Kantsadi, A.L., et al.. (2015). Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b. FEBS Letters. 589(15). 1787–1794. 34 indexed citations

Skamnaki, V.T., Willy J. Peumans, A.L. Kantsadi, et al.. (2013). Structural analysis of the Rhizoctonia solani agglutinin reveals a domain‐swapping dimeric assembly. FEBS Journal. 280(8). 1750–1763. 22 indexed citations

Kantsadi, A.L., Stella Manta, Anna‐Maria G. Psarra, et al.. (2012). The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: Synthesis, biochemical and biological assessment. European Journal of Medicinal Chemistry. 54. 740–749. 19 indexed citations

Chatzileontiadou, Demetra S.M., Stella Manta, A.L. Kantsadi, et al.. (2012). Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation. Bioorganic & Medicinal Chemistry. 20(24). 7184–7193. 24 indexed citations

Kantsadi, A.L., Joseph M. Hayes, Stella Manta, et al.. (2012). The σ‐Hole Phenomenon of Halogen Atoms Forms the Structural Basis of the Strong Inhibitory Potency of C5 Halogen Substituted Glucopyranosyl Nucleosides towards Glycogen Phosphorylase b. ChemMedChem. 7(4). 722–732. 38 indexed citations

10.

Skamnaki, V.T., et al.. (2011). A simple approach for human recombinant apolipoprotein E4 expression and purification. Protein Expression and Purification. 79(2). 251–257. 13 indexed citations

11.

Manta, Stella, Joseph M. Hayes, V.T. Skamnaki, et al.. (2010). 1-(3-Deoxy-3-fluoro-β-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies. Bioorganic & Medicinal Chemistry. 18(10). 3413–3425. 34 indexed citations

12.

Vénien‐Bryan, Catherine, Slavica Jonić, V.T. Skamnaki, et al.. (2009). The Structure of Phosphorylase Kinase Holoenzyme at 9.9 Å Resolution and Location of the Catalytic Subunit and the Substrate Glycogen Phosphorylase. Structure. 17(1). 117–127. 23 indexed citations

13.

Brown, Nick R., et al.. (2007). Cyclin B and Cyclin A Confer Different Substrate Recognition Properties on CDK2. Cell Cycle. 6(11). 1350–1359. 75 indexed citations

14.

Davies, Karen M., V.T. Skamnaki, L.N. Johnson, & Catherine Vénien‐Bryan. (2006). Structural and Functional Studies of the Response Regulator HupR. Journal of Molecular Biology. 359(2). 276–288. 12 indexed citations

15.

Oikonomakos, Nikos G., S.E. Zographos, V.T. Skamnaki, & Georgios Archontis. (2002). The 1.76 Å Resolution Crystal Structure of Glycogen Phosphorylase b Complexed with Glucose, and CP320626, a Potential Antidiabetic Drug. Bioorganic & Medicinal Chemistry. 10(5). 1313–1319. 23 indexed citations

16.

Oikonomakos, Nikos G., V.T. Skamnaki, Erzsébet Ősz, et al.. (2002). Kinetic and Crystallographic Studies of Glucopyranosylidene Spirothiohydantoin Binding to Glycogen Phosphorylase b. Bioorganic & Medicinal Chemistry. 10(2). 261–268. 45 indexed citations

17.

Tsitsanou, Katerina E., V.T. Skamnaki, & Nikos G. Oikonomakos. (2000). Structural Basis of the Synergistic Inhibition of Glycogen Phosphorylase a by Caffeine and a Potential Antidiabetic Drug. Archives of Biochemistry and Biophysics. 384(2). 245–254. 24 indexed citations

18.

Oikonomakos, Nikos G., V.T. Skamnaki, Katerina E. Tsitsanou, Nikos G. Gavalas, & L.N. Johnson. (2000). A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure. 8(6). 575–584. 100 indexed citations

19.

Oikonomakos, Nikos G., Katerina E. Tsitsanou, S.E. Zographos, et al.. (1999). Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3‐isopropyl 4‐(2‐chlorophenyl)‐1,4‐dihydro‐1‐ethyl‐2‐methyl‐pyridine‐3,5,6‐tricarboxylate. Protein Science. 8(10). 1930–1945. 36 indexed citations

20.

Zographos, S.E., Nikos G. Oikonomakos, Katerina E. Tsitsanou, et al.. (1997). The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Structure. 5(11). 1413–1425. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact